Previous studies have shown that inhibition of NF-κB suppresses inflammatory bone loss by inhibiting osteoclastogenesis in an arthritis model, suggesting that NF-κB is a major target of inflammatory bone diseases [23]. This evidence concerns the gene NFKB1 and Arthritis.